Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy. (Q33344271)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy. |
scientific article |
Statements
Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy (English)
Steven J O'Day
Peter D Boasberg
Lawrence Piro
Timothy S Kristedja
He-Jing Wang
Maureen Martin
Regina Deck
Patricia Ames
Kelly Shinn
Hannah Kim
Patricia Fournier
1 September 2002